Advertisement
News
Subscribe to MDT Magazine News

ThermoGenesis Regains Compliance With NASDAQ Listing Rules

September 13, 2010 4:36 pm | by Bio-Medicine.Org | Comments

RANCHO CORDOVA, Calif., Sept. 13 /- ThermoGenesis Corp. (Nasdaq: KOOLD ), a leading supplier of innovative products and services that process and store adult stem cells, said today that it has been informed by NASDAQ that the Company is in compliance with all NASDAQ listing standards,...

TOPICS:

Max Neeman International Expands Upon Cardiology and Device Trial Experience to Meet Increased Medical Device Development in India

September 13, 2010 4:35 pm | by Bio-Medicine.Org | Comments

RESEARCH TRIANGLE PARK, N.C., Sept. 13 /- Max Neeman International, a leading Indian CRO, announces the expansion of therapeutic focused device clinical trial services in India. Max Neeman has formed an experienced and world class team of medical device experts specializing in carrying...

TOPICS:

Can Your Child's Teacher Teach?

September 13, 2010 1:32 pm | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., September 13, 2010 — Education is an expensive investment. Historically, it has been a pre-packaged template of courses offered without warranty protection, or a money- back guarantee. The SME Education Foundation and its industry partner, Project Lead The Way...

Advertisement

USGI medical tissue anchors show durability beyond 1 year

September 13, 2010 12:33 pm | by EurekAlert | Comments

(USGI) USGI Medical Tissue Anchors show durability for over a year, overcoming a major barrier to incisionless, natural orifice surgeries.

TOPICS:

Breakthrough in drug trial offers hope for heart attack patients

September 13, 2010 12:31 pm | by EurekAlert | Comments

(University of Sheffield) New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.

TOPICS:

Genzyme's slimdown adding strength?

September 13, 2010 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

MHT life sciences report Julie Donnelly blogs: It strikes me that Genzyme might be trimming down before a marriage – either to French drug maker Sanofi-Aventis, who has proffered a rock worth $18.6 billion, or to some white knight who could ride in at the last moment, like in chick flicks.

RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti

September 13, 2010 10:36 am | by Bio-Medicine.Org | Comments

CLEVELAND, Sept. 13 /- RSB Spine, LLC, today announced that the InterPlate® L-Ti has been cleared for an additional product code (KWQ).  The L-Ti was previously cleared as an interbody fusion device. RSB Spine Chief Executive Officer John A. Redmond said: "We are excited about...

TOPICS:

Surviving healthcare reform: Get lean, learn the insurance game

September 13, 2010 10:34 am | by Diagnostic Imaging | Comments

Business consultant Pat Kroken discusses the need to batten down the hatches before provisions of the healthcare reform bill blow in next year. She suggests ways to improve internal billing and collection processes and find lost money.

TOPICS:
Advertisement

AACR Partners with EmergingMed to Link Patients with Clinical Trials in connection to SU2C Broadcast

September 13, 2010 10:34 am | by AACR | Comments

PHILADELPHIA — The American Association for Cancer Research (AACR) announces its collaboration with the clinical trial navigation system EmergingMed, to connect patients with clinical trials in connection to the Stand Up To Cancer (SU2C) broadcast which took place on Sept. 10, at 8 p.m....

TOPICS:

Merrimack Pharmaceuticals to Present at the 2010 Stifel Nicolaus Healthcare Conference

September 13, 2010 10:34 am | by Bio-Medicine.Org | Comments

CAMBRIDGE, Mass., Sept. 13 /- Merrimack Pharmaceuticals today announced that it will present at the Stifel Nicolaus 2010 Healthcare Conference in Boston. William Sullivan, Vice President of Finance, will provide a company overview at 11:30am, EDT, Friday, September 17, 2010 at the Four...

TOPICS:

COPAN Secures Japanese Patent for its Flocked Swab Innovation

September 13, 2010 10:34 am | by Bio-Medicine.Org | Comments

MURRIETA, Calif., Sept. 13 /- COPAN announced this week that it has received the Japanese patent for the invention of flocked swabs, FLOQSwabs, for collection and transfer of biological samples. The Japanese flocked swabs patent (2007-523663) is the latest addition to a growing number of...

TOPICS:

Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing

September 13, 2010 10:34 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, Sept. 13 /- Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the cobas® 8000 modular analyzer series, a Serum Work Area solution designed for diagnostic laboratories with...

TOPICS:

SentiCare moves into medication testing programs

September 13, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Southborough-based SentiCare Inc. has received an unspecified amount of funds to conduct institutional review board protocol trials involving its PillStation medical adherance system.

Allied Telesis, Hosted PACS Solutions Join Forces to Deliver Managed Cloud-Based Picture Archiving and Communications Systems (PACS) Services

September 13, 2010 8:33 am | by Bio-Medicine.Org | Comments

SAN JOSE, Calif. and WELLINGTON, Fla., Sept. 13 /- Allied Telesis Inc ., a global provider of secure IP/Ethernet switching solutions and an industry leader in the deployment of converged multi-play networks, and Hosted PACS Solutions , an application service provider (ASP) of...

TOPICS:

Regeneron Announces Presentation at the UBS Global Life Sciences Conference

September 13, 2010 8:33 am | by Bio-Medicine.Org | Comments

TARRYTOWN, N.Y., Sept. 13 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) will webcast its presentation at the UBS Global Life Sciences Conference on Monday, September 20, 2010.  The presentation is scheduled for 10:00 a.m. Eastern Time.  The session may be accessed through...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading